비강내 약물전달 기기 시장 : 용기 형태별, 용도별, 최종 사용자별, 지역별
Intranasal Drug Delivery Devices Market, By Dosage Form, By Application (Chronic Obstructive Pulmonary Disease, Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Others), By End User, By Geography
상품코드
:
1529919
리서치사
:
Coherent Market Insights
발행일
:
2024년 07월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계의 비강내 약물전달 기기 시장 규모는 2024년에 17억 달러로 추정되고, 2024년부터 2031년까지 CAGR 9.8%를 나타낼 전망이며, 2031년에는 32억 7,000만 달러에 이를 것으로 예측됩니다.
| 보고 범위 |
보고서 세부정보 |
| 기준년 |
2023년 |
시장 규모(2024년) |
17억 달러 |
| 실적 데이터 |
2019-2023년 |
예측 기간 |
2024-2031년 |
| 예측기간(2024-2031년 CAGR) |
9.80% |
금액 예측(2031년) |
32억 7,000만 달러 |
그림. 비강내 약물전달 기기 시장 지역별 점유율(%)(2024년)
세계의 비강내 약물전달 기기 시장 성장의 원동력은 비강내 약물전달 기기과 관련된 이점, 예를 들어 초기 통과 간 대사 회피, 전신 순환에 대한 신속한 약물 흡수, 코에서 뇌로의 직접 전달 등입니다. 비강내 약물전달 기기는 비침습적인 경로에서 국소 및 전신 약물 투여를 가능하게 합니다. 첨단 비강 스프레이 및 분무기 기술 개발에 주력하는 기업의 제품 투입 증가와 엄청난 투자는 시장 성장을 가속할 수 있습니다.
시장 역학 :
세계의 비강내 약물전달 기기 시장 성장의 원동력은 대체 약물 전달 경로에 대한 선호도 증가, 장기적인 약물 요법을 필요로하는 만성 질환의 이환율 증가, 비강내 약물전달 기기의 기술 진보입니다. 비강 전달이 제공하는 비침습적 성질과 신속한 작용 발현은 다양한 의약품 개발자에게 이 경로의 개척을 촉진하고 있습니다. 그러나 비강 흡수를위한 약물 분자 크기의 제한과 코 자극 및 코 막힘의 위험과 같은 요인은 시장 성장을 방해할 수 있습니다. 적용 가능한 약물 분자의 레퍼토리를 늘리고 보다 안전한 비강내 약물전달 기기 기술을 처방하는 데 중점을 둔 지속적인 연구개발은 시장 성장에 유리한 기회를 제공할 수 있습니다.
본 조사의 주요 특징
본 보고서에서는 세계의 비강내 약물전달 기기 시장을 상세하게 분석하여 2023년을 기준년으로 한 예측기간(2024-2031년) 시장 규모(10억 달러) 및 복합연간 성장률(CAGR%) 를 게시합니다.
또한 다양한 부문에 걸친 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 행렬을 설명합니다.
또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 주요 인사이트도 제공합니다.
엔터프라이즈 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 매개변수를 기반으로 세계 비강 약물전달 디바이스 시장의 주요 기업을 프로파일링합니다.
주요 기업에는 OptiNose, Merck, GlaxoSmithKline, AstraZeneca, Sanofi 등이 포함됩니다.
이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
세계의 비강내 약물전달 기기 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
목차
제1장 조사의 목적 및 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map (COM)
제3장 시장 역학, 규제 및 동향 분석
- 시장 역학
- 영향 분석
- 시장 동향
- 규제 시나리오
- 인수 및 제휴 시나리오
- 자금 조달 및 투자
- PEST 분석
- Porter's Five Forces 분석
제4장 세계의 비강 약물전달 디바이스 시장 : 코로나 바이러스(COVID-19) 팬데믹의 영향
- 전체적인 영향
- 정부의 대처
- COVID-19에 의한 시장에 대한 영향
제5장 세계의 비강내 약물전달 기기 시장 : 제형별(2019-2031년)(10억 달러)
제6장 세계의 비강 약물전달 디바이스 시장 : 용기 형태별(2019-2031년)(10억 달러)
제7장 세계의 비강 약물전달 디바이스 시장 : 용도별(2019-2031년)(10억 달러)
- 서문
- 만성 폐색성 폐질환(COPD)
- 비염
- 낭포성 섬유증
- 코 막힘
- 천식
- 기타
제8장 세계의 비강 약물전달 디바이스 시장 : 최종 사용자별(2019-2031년)(10억 달러)
제9장 세계의 비강 약물전달 디바이스 시장 : 지역별(2019-2031년)(10억 달러)
제10장 경쟁 구도
- 기업 프로파일
- GlaxoSmithKline PLC
- AstraZeneca PLC
- Pfizer, Inc.
- OptiNose, Inc.
- 3M Company
- Becton, Dickinson and Company
- Promius Pharma, LLC
- Cadila Pharmaceuticals Ltd.
- BF Ascher &Company, Inc.
- PendoPharm, Inc.
- Douglas Pharmaceuticals Ltd.
- ENT Technologies Pty. Ltd.
- NAVEH Pharma Ltd.
- Novartis AG
- Neurelis, Inc.
- Aptargroup, Inc.
제11장 분석가 추천
제12장 참고문헌 및 조사방법
AJY
영문 목차
Global intranasal drug delivery devices market is estimated to be valued at USD 1.70 Bn in 2024 and is expected to reach USD 3.27 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.8% from 2024 to 2031.
| Report Coverage |
Report Details |
| Base Year: |
2023 |
Market Size in 2024: |
US$ 1.70 Bn |
| Historical Data for: |
2019 To 2023 |
Forecast Period: |
2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: |
9.80% |
2031 Value Projection: |
US$ 3.27 Bn |
Figure. Intranasal Drug Delivery Devices Market, Share (%), By Region 2024
Global intranasal drug delivery devices market growth is driven by factor like advantages associated with intranasal drug delivery such as avoidance of first-pass hepatic metabolism, rapid drug absorption into systemic circulation, and direct nose-to-brain delivery. Intranasal drug delivery provides a non-invasive route for administering both local and systemic drugs. Rising product launches and substantial investments from players focused on developing advanced nasal spray and nebulizer technologies can drive the market growth.
Market Dynamics:
Global intranasal drug delivery devices market growth is driven by growing preference for alternate routes of drug delivery, rising incidence of chronic illnesses requiring long-term drug therapies, and technological advancements in nasal drug delivery devices. Non-invasive nature and rapid onset of action offered by intranasal delivery encourages various drug developers to explore this route. However, factors such as limitations on drug molecule size for intranasal absorption and risks of nasal irritation and congestion can hamper the market growth. Ongoing R&D focused on expanding the repertoire of applicable drug molecules and formulating safer nasal drug delivery technologies can offer market growth lucrative opportunities.
Key Features of the Study:
This report provides in-depth analysis of the global intranasal drug delivery devices market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global intranasal drug delivery devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include OptiNose, Merck, GlaxoSmithKline, AstraZeneca, and Sanofi
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global intranasal drug delivery devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Detailed Segmentation-
- By Dosage Form
- Nasal Spray
- Nasal Drop
- Nasal Gel
- Nasal Powder
- By Container Type
- Pressurized Containers
- Non-pressurized Containers
- By Application
- Chronic Obstructive Pulmonary Disease (COPD)
- Rhinitis
- Cystic Fibrosis
- Nasal Congestion
- Asthma
- Others
- By End User
- Ambulatory Surgical Centres
- Clinics
- Hospitals
- Others
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- GlaxoSmithKline PLC
- AstraZeneca PLC
- Pfizer, Inc.
- OptiNose, Inc.
- 3M Company
- Becton, Dickinson and Company
- Promius Pharma, LLC
- Cadila Pharmaceuticals Ltd.
- F. Ascher & Company, Inc.
- PendoPharm, Inc.
- Douglas Pharmaceuticals Ltd.
- ENT Technologies Pty. Ltd.
- NAVEH Pharma Ltd.
- Novartis AG
- Neurelis, Inc.
- Aptargroup, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Dosage Form
- Market Snapshot, By Container Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Intranasal Drug Delivery Devices Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Intranasal Drug Delivery Devices Market, By Dosage Form, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Nasal Spray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Nasal Drop
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Nasal Gel
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Nasal Powder
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Intranasal Drug Delivery Devices Market, By Container Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Pressurized Containers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Non-pressurized Containers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Intranasal Drug Delivery Devices Market, By Application, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Chronic Obstructive Pulmonary Disease (COPD)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Rhinitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cystic Fibrosis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Nasal Congestion
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Asthma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Intranasal Drug Delivery Devices Market, By End User, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Ambulatory Surgical Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Intranasal Drug Delivery Devices Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- GlaxoSmithKline PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca PLC
- Pfizer, Inc.
- OptiNose, Inc.
- 3M Company
- Becton, Dickinson and Company
- Promius Pharma, LLC
- Cadila Pharmaceuticals Ltd.
- B.F. Ascher & Company, Inc.
- PendoPharm, Inc.
- Douglas Pharmaceuticals Ltd.
- ENT Technologies Pty. Ltd.
- NAVEH Pharma Ltd.
- Novartis AG
- Neurelis, Inc.
- Aptargroup, Inc.
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact
관련자료
